Have Insiders Sold Jeena Sikho Lifecare Shares Recently?

We wouldn't blame Jeena Sikho Lifecare Limited (NSE:JSLL) shareholders if they were a little worried about the fact that Manish Grover, the Chairman & MD recently netted about ₹1.3b selling shares at an average price of ₹2,314. However, it's crucial to note that they remain very much invested in the stock and that sale only reduced their holding by 3.5%.

See our latest analysis for Jeena Sikho Lifecare

The Last 12 Months Of Insider Transactions At Jeena Sikho Lifecare

In fact, the recent sale by Manish Grover was the biggest sale of Jeena Sikho Lifecare shares made by an insider individual in the last twelve months, according to our records. That means that an insider was selling shares at around the current price of ₹2,220. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. We note that this sale took place at around the current price, so it isn't a major concern, though it's hardly a good sign.

In the last year Jeena Sikho Lifecare insiders didn't buy any company stock. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).

Insider Ownership

Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Jeena Sikho Lifecare insiders own about ₹38b worth of shares (which is 69% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

What Might The Insider Transactions At Jeena Sikho Lifecare Tell Us?

An insider hasn't bought Jeena Sikho Lifecare stock in the last three months, but there was some selling. And even if we look at the last year, we didn't see any purchases. But it is good to see that Jeena Sikho Lifecare is growing earnings. It is good to see high insider ownership, but the insider selling leaves us cautious. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Every company has risks, and we've spotted 2 warning signs for Jeena Sikho Lifecare (of which 1 is concerning!) you should know about.

Of course Jeena Sikho Lifecare may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.